VitaLonga

Human study · Research · 16 Nov 2026

In an NHANES III cohort, one metabolic fatty-liver pattern lined up with higher mortality than two other patterns

Source: Endocrine

What the research found

A cohort analysis of NHANES III was published online on 16 November 2026. The main contrast used 4,437 people. A sensitivity check used 12,351. The abstract does not give age or sex. Groups were cryptogenic steatotic liver disease, lean metabolic-syndrome-related fatty liver, overweight-only fatty liver (body mass index at least 25 without those metabolic abnormalities), and healthy controls. Median follow-up was 27.4 years. In fully adjusted models, the lean metabolic-syndrome pattern had higher all-cause mortality than cryptogenic disease and than overweight-only disease. Those two groups did not differ clearly from healthy controls. The overweight metabolic-syndrome pattern showed a weaker contrast. The abstract does not give the hazard ratios. When a waist-based index replaced body mass index, overweight-only disease had higher mortality than controls. An association from an older survey, followed for deaths. DOI 10.1007/s12020-026-04814-1. Not medical advice.

Evidence level: Human study. A study in people, but an association isn't proof of cause.

Read the original at Endocrine

More research news